Skip to main content
Top
Published in: Clinical Rheumatology 7/2010

01-07-2010 | Case Report

An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis

Authors: Melinda Vincze, Peter A. Molnár, Judit Tumpek, Lászlóné Szőllősi, Ágnes Gyetvai, Anikó Kapitány, Katalin Dankó

Published in: Clinical Rheumatology | Issue 7/2010

Login to get access

Abstract

The idiopathic inflammatory myopathies are systemic autoimmune diseases characterized by chronic inflammation, resulting in the progressive weakness of the proximal muscles. Myositis-specific or myositis-associated autoantibodies can often be found in serum of polymyositis and dermatomyositis patients. This autoantibody presence may play a significant role in patient diagnosis and classification. We present a female polymyositis patient characterized with serious muscle weakness and lung involvement. Anti-Jo1 antibodies were detected in the patient’s serum at the time of diagnosis. After 5 years of treatment and surveillance, recent laboratory analysis showed the presence anti-SRP antibody in her serum.
Literature
1.
go back to reference Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatol 44:83–88CrossRef Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatol 44:83–88CrossRef
2.
go back to reference Leff RL, Burgess SH, Miller FW, Love A, Plotz PH (1988) Epidemiology of adult idiopathic inflammatory myopahy: A distinct clinical onset in patients with anti-Jo-1 antibodies. Arthritis Rheum 31:D113–S121 Leff RL, Burgess SH, Miller FW, Love A, Plotz PH (1988) Epidemiology of adult idiopathic inflammatory myopahy: A distinct clinical onset in patients with anti-Jo-1 antibodies. Arthritis Rheum 31:D113–S121
3.
go back to reference Lundberg I, Chung YL (2000) Treatment and investigation of idiopathic inflammatory myopathies. Rheumatol 39:7–17CrossRef Lundberg I, Chung YL (2000) Treatment and investigation of idiopathic inflammatory myopathies. Rheumatol 39:7–17CrossRef
4.
go back to reference Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019–1038PubMed Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019–1038PubMed
5.
go back to reference Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360–374 Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360–374
6.
go back to reference Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle:clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420–428CrossRefPubMed Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle:clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420–428CrossRefPubMed
7.
go back to reference Hengstman GJ, ter Laak HJ, Vree Egberts WT (2006) Anti-signal recognition particle autoantibodies: marker of necrotising myopathy. Ann Rheum Dis 65:1635–1638CrossRefPubMed Hengstman GJ, ter Laak HJ, Vree Egberts WT (2006) Anti-signal recognition particle autoantibodies: marker of necrotising myopathy. Ann Rheum Dis 65:1635–1638CrossRefPubMed
8.
go back to reference Miller FW (1991) Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 3:902–910PubMedCrossRef Miller FW (1991) Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 3:902–910PubMedCrossRef
9.
go back to reference Lundberg IE, Grundtman C (2008) Developements in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 10:220CrossRefPubMed Lundberg IE, Grundtman C (2008) Developements in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 10:220CrossRefPubMed
10.
go back to reference Czimbalmos Á, Nagy Zs, Varga Z, Husztik P (1999) Páciens megelégedettségi vizsgálat SF-36 kérdőívvel, a magyarországi normálértékek meghatározása. Népegészségügy 1:4–19 Czimbalmos Á, Nagy Zs, Varga Z, Husztik P (1999) Páciens megelégedettségi vizsgálat SF-36 kérdőívvel, a magyarországi normálértékek meghatározása. Népegészségügy 1:4–19
Metadata
Title
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis
Authors
Melinda Vincze
Peter A. Molnár
Judit Tumpek
Lászlóné Szőllősi
Ágnes Gyetvai
Anikó Kapitány
Katalin Dankó
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1394-6

Other articles of this Issue 7/2010

Clinical Rheumatology 7/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.